Medical News

RSS

UMass Memorial Health Care to implement Accenx' interoperability platform for physician practice integration

Accenx(TM), a leading provider of health information exchange and interoperability solutions, announced today that UMass Memorial Health Care, clinical partner of University of Massachusetts Medical School and the largest healthcare system in Central and Western Massachusetts, has selected the Accenx Exchange(TM) interoperability platform to rapidly establish a health information exchange with its community physicians.

15 Oct 2009

College of American Pathologists honours Dr. Kevin B. Dole as the 2009 Pathologist of the Year

Kevin B. Dole, MD, FCAP, was named the 2009 Pathologist of the Year at a ceremony held on October 11, 2009, in Washington DC at CAP '09 -- The Pathologists' Meeting(TM).

15 Oct 2009

Access Pharmaceuticals' update on its European commercial launch of Mugard

ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.

15 Oct 2009

Aethlon Medical to present data on HVC patients treated with its Hemopurifier at the 42nd ASN meeting

Aethlon Medical, Inc. disclosed today that clinical data resulting from the treatment of Hepatitis-C (HCV) infected patients with the Aethlon Hemopurifier® will be presented at the 42nd Annual Meeting & Scientific Exposition of the American Society of Nephrology (ASN).

15 Oct 2009

Lovelace Health Plan to implement Portico’s Choreo Contracting Solution

Portico Systems, the leader in Integrated Provider Management solutions, has been selected by Lovelace Health Plan (LHP), a wholly owned subsidiary of Ardent Health Services. LHP will leverage Portico’s Choreo Contracting Solution to transform its paper-based provider contract process to a systematic process, which enables automated and workflow driven contract administration, negotiation and communication.

15 Oct 2009

Overview of innovative technology for treating ischemic and autoimmune disorders

Pluristem Therapeutics Inc. today announced that it will present at the New England-Israel Life Sciences Summit at the Brandeis International Business School in Waltham, Mass. Zami Aberman, chairman and CEO of Pluristem will present an update on the company and an overview of its technology at 9:40 EDT, Oct 27, 2009.

15 Oct 2009

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

Writers and producers from The Soloist, "Grey's Anatomy," "United States of Tara," "90210," and others were honored by the Substance Abuse and Mental Health Services Administration (SAMHSA) for increasing awareness of mental health issues and the power of recovery at the 2009 Voice Awards last night. The event was hosted by Academy Award-winning actor and mental health consumer Richard Dreyfuss at Paramount Studios in Los Angeles.

15 Oct 2009

FDA launches web page with information on how to dispose of certain drugs

The U.S. Food and Drug Administration today launched a Web page for consumers with information on how to dispose of certain drugs, including several high-potency opioids and other selected controlled substances.

15 Oct 2009

Arrayit announces collaboration with European Space Agency for mission-critical contribution

Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences technology leader, announces a collaboration with the European Space Agency.

15 Oct 2009

NHGRI grants BioNanomatrix $833,490 for commercial development of its NanoAnalyzer system

BioNanomatrix, Inc., a developer of breakthrough single-molecule genomic analysis technology, today announced receipt of two new supplemental grants totaling $833,490 from the National Human Genome Research Institute (NHGRI) of the U.S. National Institutes of Health (NIH). The funding is intended to support further commercial development of BioNanomatrix's nanoscale whole genome imaging and analysis platform.

15 Oct 2009

Mylan Pharmaceuticals receives approval for Topiramate Capsules

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules (Sprinkle), 15 mg and 25 mg.

15 Oct 2009

MDS secures international cooperation to help Canadian teenager with malignant blood disorder

The Myelodysplastic Syndromes (MDS) Foundation says a wide range of international cooperation has been secured to help 18-year-old Wes Laporte of Ontario get treatment for a life-threatening condition in the US.

15 Oct 2009

Merck KGaA and Dyesol sign joint development agreement

Merck KGaA and Dyesol Limited have signed an agreement to collaborate in the development of electrolytes for use in Dye Solar Cells (DSC).

15 Oct 2009

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

AcelRx Pharmaceuticals, Inc. announced today that results of its Phase 1 studies evaluating the pharmacokinetics of its oral transmucosal NanoTab(TM) formulation of sufentanil will be featured in two oral presentations at the upcoming American Society of Anesthesiologists Annual Meeting in New Orleans.

15 Oct 2009

Ultimate Software's healthcare customers report significant improvements after implementing UltiPro

Ultimate Software, a leading provider of end-to-end strategic human resources, payroll, and talent management solutions, announced today that long-term healthcare customers, including Homewood Retirement Centers, Mather LifeWays, and Holiday Home Health, are reporting significant improvements as a result of UltiPro’s comprehensive human capital management (HCM) features—including UltiPro’s sophisticated reporting, Software-as-a-Service (SaaS) model, and robust functionality.

15 Oct 2009

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

Four-time Olympic gold medal winner and three-time WNBA Most Valuable Player Lisa Leslie is teaming with Covidien, a leading global provider of healthcare products, to launch an educational program and Web site, www.MyLiverCancerOptions.com, that provide information to help patients and their families understand the treatment options available to manage liver cancer.

15 Oct 2009

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

The NFL and National Dairy Council (NDC) today launch Fuel Up to Play 60, a new initiative aimed at tackling childhood obesity by giving youth a voice in changing the school nutrition and physical activity environment. The program will reach 36 million youth in 60,000 elementary, middle and high schools during the 2009/2010 school year.

15 Oct 2009

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).

15 Oct 2009

Prometheus Laboratories introduces three new cancer diagnostic products

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource Dx, ProOnc Squamous Dx and ProOnc Mesothelioma Dx. Each of these tests is based on recently developed, highly sensitive microRNA technology.

15 Oct 2009

Breathe Right "Extra" to help consumers sleep better at night

While many of us will never know the feeling of playing in a professional football game, we all should know the feeling of getting a good night's sleep. However, many adults suffer from night-time congestion, a good night's sleep can be as elusive as a speedy running back - until now.

15 Oct 2009

Medical News

UMass Memorial Health Care to implement Accenx' interoperability platform for physician practice integration

College of American Pathologists honours Dr. Kevin B. Dole as the 2009 Pathologist of the Year

Access Pharmaceuticals' update on its European commercial launch of Mugard

Aethlon Medical to present data on HVC patients treated with its Hemopurifier at the 42nd ASN meeting

Lovelace Health Plan to implement Portico’s Choreo Contracting Solution

Overview of innovative technology for treating ischemic and autoimmune disorders

SAMHSA honors contributors to mental health recovery at the 2009 Voice Awards

FDA launches web page with information on how to dispose of certain drugs

Arrayit announces collaboration with European Space Agency for mission-critical contribution

NHGRI grants BioNanomatrix $833,490 for commercial development of its NanoAnalyzer system

Mylan Pharmaceuticals receives approval for Topiramate Capsules

MDS secures international cooperation to help Canadian teenager with malignant blood disorder

Merck KGaA and Dyesol sign joint development agreement

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

Ultimate Software's healthcare customers report significant improvements after implementing UltiPro

Olympic gold medal winner Lisa Leslie and Covidien launch new liver cancer education program

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Prometheus Laboratories introduces three new cancer diagnostic products

Breathe Right "Extra" to help consumers sleep better at night

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News